Atrium Therapeutics, Inc. Common Stock (RNA) stock news · rev $18.8M
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
This RNA news page leads with what Atrium Therapeutics, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for RNA yet. We will not pad this page with generic market recap.
Latest reported RNA revenue for 2025-12-31 was $18.8M. Net income was -$684.6M. Revenue was up 72.1% from 2024-12-31 to 2025-12-31. RNA currently screens at market cap $217.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RNA stock page; for the tape open the quote page.
RNA stock news FAQ
What are RNA's latest revenue and net income?
Latest cached Atrium Therapeutics, Inc. Common Stock (RNA) revenue for Dec 31, 2025 was $18.8M. Net income was -$684.6M. Statements: https://lician.com/financials/rna
How did RNA revenue change from the prior cached period?
Cached Atrium Therapeutics, Inc. Common Stock (RNA) revenue was up 72.1% from $10.9M (Dec 31, 2024) to $18.8M (Dec 31, 2025). Statements: https://lician.com/financials/rna
What is RNA's market cap?
Atrium Therapeutics, Inc. Common Stock (RNA) market cap is $217.5M on the latest cached fundamentals snapshot.
What kind of company is RNA?
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Where is RNA stock news listed?
Cached stock news for Atrium Therapeutics, Inc. Common Stock (RNA) is listed at https://lician.com/news/rna. Filings: https://lician.com/sec/rna
Not investment advice.